NCT00767871View on ClinicalTrials.gov

Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

December 31, 2008

Conditions
Panic Disorder
Interventions
DRUG

Lexapro

12 week treatment with lexapro

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Samsung Medical Center

OTHER

NCT00767871 - Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder | Biotech Hunter | Biotech Hunter